SELARL PHARMACIE DE LA SIGNORE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE LA SIGNORE is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MARIGNANE (13700), this company of category PME shows in 2018 a revenue of 2.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE LA SIGNORE (SIREN 531028314)
Indicator 2019 2018 2017 2016
Revenue N/C 2 043 444 € 2 189 585 € 2 305 728 €
Net income 154 750 € 153 382 € 168 346 € 184 218 €
EBITDA N/C 253 716 € 301 794 € 332 212 €
Net margin N/C 7.5% 7.7% 8.0%

Revenue and income statement

In 2019, SELARL PHARMACIE DE LA SIGNORE generates positive net income of 155 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2019: 184 k€ -> 155 k€.

Net income (2019) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

154 750 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 50%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2019) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

50.149%

Financial autonomy (2019) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

42.322%

Asset age ratio (2019) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

6.0%

Solvency indicators evolution
SELARL PHARMACIE DE LA SIGNORE

Sector positioning

Debt ratio
50.15 2019
2017
2018
2019
Q1: 35.66
Med: 104.09
Q3: 243.68
Good -23 pts over 3 years

In 2019, the debt ratio of SELARL PHARMACIE DE LA SI... (50.15) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
42.32% 2019
2017
2018
2019
Q1: 22.98%
Med: 40.69%
Q3: 60.85%
Good +13 pts over 3 years

In 2019, the financial autonomy of SELARL PHARMACIE DE LA SI... (42.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
3.62 years 2018
2017
2018
Q1: 1.85 years
Med: 5.41 years
Q3: 9.79 years
Good

In 2018, the repayment capacity of SELARL PHARMACIE DE LA SI... (3.62) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 50.23. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2019) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

50.235

Liquidity indicators evolution
SELARL PHARMACIE DE LA SIGNORE

Sector positioning

Liquidity ratio
50.23 2019
2017
2018
2019
Q1: 119.98
Med: 167.07
Q3: 236.26
Watch

In 2019, the liquidity ratio of SELARL PHARMACIE DE LA SI... (50.23) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
6.95x 2018
2017
2018
Q1: 1.93x
Med: 6.3x
Q3: 12.7x
Good

In 2018, the interest coverage of SELARL PHARMACIE DE LA SI... (7.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2019) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2019) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2019) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2019) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DE LA SIGNORE

Positioning of SELARL PHARMACIE DE LA SIGNORE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 205 transactions of similar company sales in 2019, the value of SELARL PHARMACIE DE LA SIGNORE is estimated at 1 923 268 € (range 1 145 611€ - 2 730 035€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2019
205 transactions
1145k€ 1923k€ 2730k€
1 923 268 € Range: 1 145 611€ - 2 730 035€
NAF 5 année 2019

Valuation method used

Net Income Multiple
154 750 € × 12.4x = 1 923 269 €
Range: 1 145 611€ - 2 730 035€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 205 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE LA SIGNORE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DE LA SIGNORE

What is the revenue of SELARL PHARMACIE DE LA SIGNORE ?

The revenue of SELARL PHARMACIE DE LA SIGNORE in 2018 is 2.0 M€.

Is SELARL PHARMACIE DE LA SIGNORE profitable?

Yes, SELARL PHARMACIE DE LA SIGNORE generated a net profit of 155 k€ in 2019.

Where is the headquarters of SELARL PHARMACIE DE LA SIGNORE ?

The headquarters of SELARL PHARMACIE DE LA SIGNORE is located in MARIGNANE (13700), in the department Bouches-du-Rhone.

Where to find the tax return of SELARL PHARMACIE DE LA SIGNORE ?

The tax return of SELARL PHARMACIE DE LA SIGNORE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE LA SIGNORE operate?

SELARL PHARMACIE DE LA SIGNORE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.